Peter J. Fischinger - Concepedia

Author

Peter J. Fischinger

Also Known As

Fischinger, P. J., Fischinger, Peter J., P Fischinger, P J Fischinger, P. Fischinger, P. J. FISCHINGER, P. J. Fischinger, P.J. FISCHINGER, P.J. Fischinger, PETER J. FISCHINGER

136

Publications

7.3K

Citations

H-Index

Concepts

All Affiliations

National Cancer Institute National Institutes of Health Max Planck Institute for Biology Cancer Research Center Duke Medical Center

About

Peter J. Fischinger is an author at National Cancer Institute specializing in medicine, virology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	41	80	6.2K
2	Natural Sciences	5	5	568
3	Allergy	5	5	588
4	Biology	2	2	39
5	Biochemistry	1	1	27

Peter J. Fischinger

Publications

Citations

H-Index

Page 1

	Year	Citations
Antibodies that inhibit fusion of human immunodeficiency virus-infected cells bind a 24-amino acid sequence of the viral envelope, gp120. J R Rusche, Kashi Javaherian, Charlene McDanal, Proceedings of the National Academy of Sciences Viral EnvelopeHuman RetrovirusImmunologyAntiviral ResponseAntiviral Therapy	1988	623
Rapid Cell Culture Assay Technique for Murine Leukaemia Viruses Robert H. Bassin, NANCY TUTTLE, Peter J. Fischinger Nature ImmunologyMurine Leukaemia VirusesVirologyAdult T-cell Leukemia-lymphomaMedicine	1971	358
Characterization of Envelope and Core Structural Gene Products of HTLV-III with Sera from AIDS Patients W. Gerard Robey, Bijan Safai, Stephen Oroszlan, Science	1985	353
HTLV-III/LAV-Neutralizing Antibodies to an <i>E. coli</i> -Produced Fragment of the Virus Envelope Scott D. Putney, Thomas J. Matthews, W. Gerard Robey, Science	1986	332
Simple, Rapid, Quantitative, Syncytium-Forming Microassay for the Detection of Human Immunodeficiency Virus Neutralizing Antibody P L Nara, W. Hatch, Nancy M. Dunlop, AIDS Research and Human Retroviruses Microtiter DishesViral ReplicationImmunocytochemical TechniqueImmunologySyncytium-forming Microassay	1987	275
Activation of the Transforming Potential of a Normal Cell Sequence: A Molecular Model for Oncogenesis D. G. Blair, Marianne Oskarsson, T.Gordon Wood, Science Viral ReplicationMolecular BiologyCell ProliferationCell GrowthCell Specialization	1981	246
Prospect for prevention of human immunodeficiency virus infection: purified 120-kDa envelope glycoprotein induces neutralizing antibody. W G Robey, L O Arthur, Thomas J. Matthews, Proceedings of the National Academy of Sciences Gp120 Subunit VaccineAllergyHuman RetrovirusImmunologyAntiviral Response	1986	233
Emergence of viruses resistant to neutralization by V3-specific antibodies in experimental human immunodeficiency virus type 1 IIIB infection of chimpanzees Peter L. Nara, Linda Smit, Nancy M. Dunlop, Journal of Virology ImmunologyViral PathogenesisImmunotherapyIiib InfectionHuman Retrovirus	1990	226
Isolation of murine sarcoma virus‐transormed mouse cells which are negative for leukemia virus from agar suspension cultures Robert H. Bassin, NANCY TUTTLE, Peter J. Fischinger International Journal of Cancer Viral ReplicationAgar Suspension CulturesMedicineViral PathogenesisPathology	1970	224
Restricted neutralization of divergent human T-lymphotropic virus type III isolates by antibodies to the major envelope glycoprotein. Thomas J. Matthews, A J Langlois, W G Robey, Proceedings of the National Academy of Sciences VaccinationMajor Envelope GlycoproteinGp120 AntigenMolecular VirologyAllergy	1986	204

Page 1